uk 68798 has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (26.09) | 18.2507 |
| 2000's | 12 (52.17) | 29.6817 |
| 2010's | 4 (17.39) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Árpádffy-Lovas, T; Baczkó, I; Husti, Z; Varró, A; Virág, L | 1 |
| Adabag, S; Anand, V; Li, JM; McFalls, E; Tholakanahalli, V; Vakil, K | 1 |
| Bhavnani, SP; Clyne, CA; Coleman, CI; Guertin, D; Kluger, J; Shafi, NA; White, CM; Yarlagadda, RK | 1 |
| Ahmad, K; Akhtari, S; Dorian, P; Korley, V; Mangat, I; Newman, D; O'Connell, T; O'Donnell, S; Pinter, A; Posan, E | 1 |
| Banchs, JE; Baquero, GA; Depalma, S; Gonzalez, MD; Naccarelli, GV; Penny-Peterson, ED; Samii, SM; Wolbrette, DL; Young, SK | 1 |
| Crijns, HJ; Vos, MA | 1 |
| Singh, BN | 1 |
| Khan, MH | 1 |
| Branyas, NA; Fogel, RI; Freeland, S; Padanilam, BJ; Prystowsky, EN; Rardon, DP; Rippy, JS | 1 |
| Reiffel, JA | 1 |
| Bauman, JL; Kehoe, RF; Leal, S; Mykytsey, A; Razminia, M; Saleem, M; Wang, T; Zheutlin, T | 1 |
| Kolb, C; Ndrepepa, G; Zrenner, B | 1 |
| Bashir, Y; Camm, AJ; Campbell, RW; Cobbe, SM; Jordaens, L; Kingma, JH; Møller, M; Rasmussen, HS; Thomsen, PE; Wong, C | 1 |
| Blomström-Lundqvist, C; Olsson, S; Rasmussen, HS; Wohlfart, B; Yuan, S | 1 |
| Borganelli, SM; Crawford, DM; Echt, DS; Friedrich, T; Lee, JT; Murray, KT; Roden, DM; Vorperian, V | 1 |
| Chen, J; Eto, K; Hashimoto, K; Ni, C; Xue, Y | 1 |
| Cantù, F; Napolitano, C; Paganini, V; Priori, SG; Schwartz, PJ | 1 |
| Bacchi, L; Biffi, M; Bitonti, F; Boriani, G; Branzi, A; Butrous, G; De Simone, N; Martignani, C; Zannoli, R | 1 |
| Anderson, ME; Bonney, S; Mazur, A; Roden, DM | 1 |
| Lauer, MR | 1 |
| Bergonzi, M; Rinaldi, JP; Saoudi, N; Yaici, K | 1 |
| Biffi, M; Borggrefe, M; Boriani, G; Brachmann, J; Butrous, GS; Capucci, A; Kornacewicz-Jack, Z; Lubinski, A; Niederle, R; Wnuk-Wojnar, AM | 1 |
| Anderson, MH; Bashir, Y; Camm, AJ; Gibson, S; Heald, S; Kulakowski, P; Malik, M; Paul, V | 1 |
4 review(s) available for uk 68798 and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Myocardial repolarization and drugs. Impossibility to predict the dominance of anti-arrhythmic over pro-arrhythmic effects of drugs due to differential and ventricular electrical remodeling.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disease Models, Animal; Humans; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Torsades de Pointes | 2001 |
Significance and control of cardiac arrhythmias in patients with congestive cardiac failure.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Death, Sudden, Cardiac; Defibrillators, Implantable; Drug Therapy, Combination; Heart Failure; Humans; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Ventricular Fibrillation | 2002 |
Oral class III antiarrhythmics: what is new?
Topics: Amiodarone; Anti-Arrhythmia Agents; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides; Tachycardia, Supraventricular; Tachycardia, Ventricular; Treatment Outcome | 2004 |
Molecular biology of the long QT syndrome: impact on management.
Topics: Action Potentials; Adrenergic Antagonists; Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiotonic Agents; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 3; Chromosomes, Human, Pair 7; Disease Models, Animal; Electrocardiography; Genetic Therapy; Guinea Pigs; Heart Rate; Humans; Intercellular Signaling Peptides and Proteins; Long QT Syndrome; Mexiletine; Molecular Biology; Myocardium; Peptides; Phenethylamines; Potassium; Potassium Channel Blockers; Potassium Channels; Receptors, Adrenergic; Risk Factors; Sodium Channel Blockers; Sodium Channels; Sulfonamides; Syncope; Tachycardia, Ventricular | 1997 |
7 trial(s) available for uk 68798 and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Clinical experience with dofetilide in the treatment of patients with atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Phenethylamines; Practice Guidelines as Topic; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome | 2003 |
Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Monitoring; Female; Flecainide; Follow-Up Studies; Humans; Inpatients; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Propafenone; Recurrence; Sotalol; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome; Ventricular Function, Left; Withholding Treatment | 2007 |
Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. Dofetilide Arrhythmia Study Group.
Topics: Aged; Anti-Arrhythmia Agents; Electric Stimulation; Electrophysiology; Europe; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Phenethylamines; Sulfonamides; Tachycardia, Ventricular | 1995 |
A randomized, double-blind, placebo-controlled, dose-ranging study of dofetilide in patients with inducible sustained ventricular tachyarrhythmias.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Double-Blind Method; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Phenethylamines; Sulfonamides; Tachycardia, Ventricular | 1995 |
Repolarization changes in a double-blind crossover study of dofetilide versus sotalol in the treatment of ventricular tachycardia.
Topics: Anti-Arrhythmia Agents; Cross-Over Studies; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Phenethylamines; Sotalol; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome | 2000 |
Pause-dependent polymorphic ventricular tachycardia during long-term treatment with dofetilide: a placebo-controlled, implantable cardioverter-defibrillator-based evaluation.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Torsades de Pointes | 2001 |
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Phenethylamines; Sotalol; Statistics as Topic; Sulfonamides; Tachycardia, Ventricular | 2001 |
12 other study(ies) available for uk 68798 and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Different effects of amiodarone and dofetilide on the dispersion of repolarization between well-coupled ventricular and Purkinje fibers
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Dogs; Electrocardiography; Female; Heart Ventricles; Humans; Male; Microelectrodes; Models, Animal; Phenethylamines; Purkinje Fibers; Sulfonamides; Tachycardia, Ventricular | 2021 |
Discontinuation of Dofetilide From QT Prolongation and Ventricular Tachycardia in the Real World.
Topics: Aged; Anti-Arrhythmia Agents; Electrocardiography; Humans; Kaplan-Meier Estimate; Middle Aged; Phenethylamines; Sulfonamides; Tachycardia, Ventricular | 2016 |
The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators.
Topics: Aged; Anti-Arrhythmia Agents; Cohort Studies; Confidence Intervals; Connecticut; Defibrillators, Implantable; Digoxin; Electrophysiology; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Multivariate Analysis; Phenethylamines; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 2010 |
Efficacy and safety of dofetilide in the treatment of frequent ventricular tachyarrhythmias after amiodarone intolerance or failure.
Topics: Amiodarone; Cohort Studies; Female; Humans; Male; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Time Factors; Treatment Failure; Treatment Outcome | 2011 |
Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Topics: Aged; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Coronary Artery Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Dose-Response Relationship, Drug; Electric Countershock; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Phenethylamines; Recurrence; Stroke Volume; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation; Ventricular Function, Left | 2012 |
Atypical proarrhythmia with dofetilide: monomorphic VT and exercise-induced torsade de pointes.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Exercise Test; Humans; Male; Middle Aged; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Torsades de Pointes; Ventricular Premature Complexes | 2005 |
Late dofetilide-associated life-threatening proarrhythmia.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Defibrillators, Implantable; Electrocardiography; Humans; Male; Middle Aged; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Ventricular Fibrillation | 2008 |
Effect of dofetilide on cardiac repolarization in patients with ventricular tachycardia. A study using simultaneous monophasic action potential recordings from two sites in the right ventricle.
Topics: Action Potentials; Adult; Aged; Anti-Arrhythmia Agents; Diastole; Female; Heart Conduction System; Humans; Male; Middle Aged; Phenethylamines; Potassium Channel Blockers; Sulfonamides; Tachycardia, Ventricular; Ventricular Function, Right | 1994 |
Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Digitalis; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; Epinephrine; Female; Male; Myocardial Infarction; Myocardial Reperfusion; Phenethylamines; Plants, Medicinal; Plants, Toxic; Sulfonamides; Tachycardia, Ventricular; Ventricular Fibrillation | 1996 |
Dofetilide: is the treatment worse than the disease?
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Humans; Phenethylamines; Sulfonamides; Tachycardia, Ventricular | 2001 |
Dofetilide: what role in the treatment of ventricular tachyarrhythmias?
Topics: Anti-Arrhythmia Agents; Humans; Phenethylamines; Sulfonamides; Tachycardia, Ventricular | 2001 |
Prediction of antiarrhythmic efficacy of class I and III agents in patients with ventricular tachycardia by signal-averaged ECG analysis.
Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Electrocardiography; Female; Heart Conduction System; Humans; Male; Middle Aged; Phenethylamines; Predictive Value of Tests; Procainamide; Signal Processing, Computer-Assisted; Sulfonamides; Tachycardia, Ventricular; Time Factors | 1992 |